Abstract
We incorporate the perspectives of research participants in a clinical trial of DBS for TBI about investigator and sponsor responsibilities with respect to posttrial access to a functioning embedded medical device. We argue that investigators owe a duty of transparency about posttrial access to device maintenance, upgrades, or removal as part of an ongoing informed consent process.
| Original language | English (US) |
|---|---|
| Title of host publication | The Future of Medical Device Regulation |
| Subtitle of host publication | Innovation and Protection |
| Publisher | Cambridge University Press |
| Pages | 256-267 |
| Number of pages | 12 |
| ISBN (Electronic) | 9781108975452 |
| ISBN (Print) | 9781108838634 |
| DOIs | |
| State | Published - Jan 1 2022 |
All Science Journal Classification (ASJC) codes
- General Social Sciences